SI0869958T1 - Novel indole-2,3-dione-3-oxime derivatives - Google Patents

Novel indole-2,3-dione-3-oxime derivatives

Info

Publication number
SI0869958T1
SI0869958T1 SI9730698T SI9730698T SI0869958T1 SI 0869958 T1 SI0869958 T1 SI 0869958T1 SI 9730698 T SI9730698 T SI 9730698T SI 9730698 T SI9730698 T SI 9730698T SI 0869958 T1 SI0869958 T1 SI 0869958T1
Authority
SI
Slovenia
Prior art keywords
dione
het
oxime derivatives
novel indole
ring
Prior art date
Application number
SI9730698T
Other languages
English (en)
Slovenian (sl)
Inventor
Frank W�Tjen
Jorgen Drejer
Original Assignee
Neurosearch A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch A/S filed Critical Neurosearch A/S
Publication of SI0869958T1 publication Critical patent/SI0869958T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI9730698T 1996-10-01 1997-10-01 Novel indole-2,3-dione-3-oxime derivatives SI0869958T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK106996 1996-10-01
DK127796 1996-11-13
PCT/DK1997/000418 WO1998014447A1 (en) 1996-10-01 1997-10-01 Novel indole-2,3-dione-3-oxime derivatives
EP97941880A EP0869958B1 (en) 1996-10-01 1997-10-01 Novel indole-2,3-dione-3-oxime derivatives

Publications (1)

Publication Number Publication Date
SI0869958T1 true SI0869958T1 (en) 2005-06-30

Family

ID=26065167

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730698T SI0869958T1 (en) 1996-10-01 1997-10-01 Novel indole-2,3-dione-3-oxime derivatives

Country Status (29)

Country Link
US (3) US6124285A (bg)
EP (1) EP0869958B1 (bg)
JP (1) JP3319762B2 (bg)
KR (1) KR100492052B1 (bg)
CN (1) CN1093859C (bg)
AT (1) ATE286052T1 (bg)
AU (1) AU716435B2 (bg)
BG (1) BG63874B1 (bg)
BR (1) BR9706765A (bg)
CA (1) CA2238410C (bg)
CZ (1) CZ297938B6 (bg)
DE (1) DE69732090T2 (bg)
DK (1) DK0869958T3 (bg)
EE (1) EE9800144A (bg)
ES (1) ES2235253T3 (bg)
HK (1) HK1017682A1 (bg)
HU (1) HU225145B1 (bg)
IL (1) IL124563A (bg)
IS (1) IS2123B (bg)
NO (1) NO310722B1 (bg)
NZ (1) NZ330456A (bg)
PL (1) PL193041B1 (bg)
PT (1) PT869958E (bg)
RU (1) RU2190612C2 (bg)
SI (1) SI0869958T1 (bg)
SK (1) SK282729B6 (bg)
TR (1) TR199800956T1 (bg)
UA (1) UA54403C2 (bg)
WO (1) WO1998014447A1 (bg)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
DE69922936T2 (de) * 1998-03-31 2005-12-08 Neurosearch A/S Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten
ATE420636T1 (de) 1999-05-19 2009-01-15 Painceptor Pharma Corp Hemmer der protonenabhängigen kationenkanäle und deren verwendung in der behandlung von ischemiebedingten erkrankungen
CN1298704C (zh) * 2000-01-24 2007-02-07 神经研究公司 具有神经营养活性的靛红衍生物
IT1318636B1 (it) * 2000-07-21 2003-08-27 Roberto Pellicciari Derivati dell'acido 2- o 3- tenoico ad attivita' antagonista deirecettori del glutammato.
EP1361878A1 (en) * 2001-02-15 2003-11-19 Neurosearch A/S Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
JP2005522408A (ja) 2001-07-13 2005-07-28 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ５−ＨＴ受容体リガントとしてのヘキサヒドロアゼピノ（４，５−ｇ）インドールおよびインドリン
JP2006503011A (ja) * 2002-08-22 2006-01-26 ニューロサーチ、アクティーゼルスカブ インドール−２，３−ジオン−３−オキシム誘導体の対掌体の製造方法
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
CA2630617C (en) * 2005-11-23 2014-03-25 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
US20080004306A1 (en) * 2006-04-10 2008-01-03 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
US20080021034A1 (en) * 2006-04-10 2008-01-24 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
WO2008031831A2 (en) * 2006-09-12 2008-03-20 Neurosearch A/S Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein
US20080108622A1 (en) * 2006-10-19 2008-05-08 Eisenach James C Combination therapy for the treatment of pain
US20080108603A1 (en) * 2006-10-19 2008-05-08 Eisenach James C Combination therapy for the treatment of pain
WO2010104324A2 (ko) * 2009-03-10 2010-09-16 한국과학기술연구원 베타-아밀로이드 집적체 및 피브릴에 우수한 결합 친화도를 가지는 할로겐화 이소인돌론 화합물, 및 이의 제조 방법 및 용도
CN102653538A (zh) * 2011-03-04 2012-09-05 爱斯医药科技(南京)有限公司 Spd-502的制备方法
AU2016255434C1 (en) 2015-04-29 2021-09-23 Rapport Therapeutics, Inc. Azabenzimidazoles and their use as AMPA receptor modulators
CA2984305C (en) * 2015-04-29 2021-12-28 Janssen Pharmaceutica Nv Indolone compounds and their use as ampa receptor modulators
WO2016176457A1 (en) 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
AU2016255424B2 (en) 2015-04-29 2020-10-08 Janssen Pharmaceutica Nv Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2076948C (en) * 1991-08-28 2002-04-16 Frank Watjen Isatineoxime derivatives, their preparation and use
US5721230A (en) 1993-05-10 1998-02-24 Hoffmann-La Roche Inc. Substituted pyrroles
ATE161259T1 (de) * 1993-05-13 1998-01-15 Neurosearch As Ampa antagonisten und behandlungsmethode
DK81593D0 (da) * 1993-07-07 1993-07-07 Neurosearch As Nye isatinoximderivater, deres fremstilling og anvendelse
US5917053A (en) * 1994-09-14 1999-06-29 Neurosearch A/S Indole-2,3-dione-3-oxime derivatives, their preparation and use
DE69514533T2 (de) * 1994-09-14 2000-07-06 Neurosearch A/S, Ballerup Kondensierte indole und chinoxalinderivate, ihre herstellung und verwendung als glutamatantagonisten
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму

Also Published As

Publication number Publication date
JP3319762B2 (ja) 2002-09-03
CZ160698A3 (cs) 1998-10-14
US6693111B1 (en) 2004-02-17
JP2000501432A (ja) 2000-02-08
CN1093859C (zh) 2002-11-06
IS2123B (is) 2006-07-14
US6124285A (en) 2000-09-26
BR9706765A (pt) 1999-09-14
RU2190612C2 (ru) 2002-10-10
BG102489A (bg) 1999-04-30
HU225145B1 (en) 2006-07-28
BG63874B1 (bg) 2003-04-30
CA2238410A1 (en) 1998-04-09
PL193041B1 (pl) 2007-01-31
MX9804365A (es) 1998-10-31
CN1207100A (zh) 1999-02-03
IL124563A0 (en) 1998-12-06
KR19990071823A (ko) 1999-09-27
PL327073A1 (en) 1998-11-23
EE9800144A (et) 1998-10-15
ATE286052T1 (de) 2005-01-15
NO982466L (no) 1998-07-31
SK282729B6 (sk) 2002-11-06
PT869958E (pt) 2005-05-31
CZ297938B6 (cs) 2007-05-02
DE69732090T2 (de) 2005-12-29
AU4376897A (en) 1998-04-24
NO310722B1 (no) 2001-08-20
DK0869958T3 (da) 2005-04-18
USRE38200E1 (en) 2003-07-22
ES2235253T3 (es) 2005-07-01
UA54403C2 (uk) 2003-03-17
NO982466D0 (no) 1998-05-29
DE69732090D1 (de) 2005-02-03
SK67698A3 (en) 1998-11-04
CA2238410C (en) 2007-06-12
TR199800956T1 (xx) 1998-12-21
NZ330456A (en) 1998-11-25
HK1017682A1 (en) 1999-11-26
IL124563A (en) 2005-05-17
EP0869958B1 (en) 2004-12-29
KR100492052B1 (ko) 2005-09-30
WO1998014447A1 (en) 1998-04-09
EP0869958A1 (en) 1998-10-14
HUP9901630A2 (hu) 1999-08-30
IS4748A (is) 1998-05-18
HUP9901630A3 (en) 2001-11-28
AU716435B2 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
HK1017682A1 (en) Novel indole-2,3-dione-3-oxime derivatives
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
HUP0204418A2 (hu) NHE-1 inhibitor hatású N-[(helyettesített öttagú, di- vagy triaza-, kétszeresen telítetlen gyűrű)-karbonil]-guanidin-származékok és alkalmazásuk
BG105969A (bg) Аминопроизводни като инхибитори на протеаза
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
ATE157355T1 (de) 3-benzyliden-1-carbamoyl-2-pyrrolidon-analoga
NZ334531A (en) Quinoxalin derivatives as Protein kinase C inhibitors
NO174387C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive isoindolonderivater
IL102703A (en) N-sulfonyl indoline derivatives carrying an amide functional group, their preparation and pharmaceutical compositions containing them
DE69924292D1 (de) Pyrazol verbindungen und ihre verwendung
NO305287B1 (no) AMPA antagonister
BG94282A (bg) 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они
ATE302772T1 (de) 2-(1h-indol-3-yl)-2-oxo-acetamide mit antitumoraler wirkung
CO5140116A1 (es) Compuestos espiro derivados de imidazo-benzazepina con actividad antihistaminica y sus procesos de obtencion a partir de sus intermediarios de sintesis
NZ335252A (en) Substituted 3-thia-1,2,3,4-tetrahydrocarbazole, 6,7,8,9-tetrahydropyrido[1,2-a]indole, 4,5-dihydro-thiopyrano[3,4-b]indole, pyrano[3,4-b]indole or beta-carbolinyl derivatives
IL91648A (en) Amino acid quinoline and naphthyridine derivatives, their preparation and pharmaceutical compositions containing them
TW367328B (en) Benzofuro[3,2-b]pyridine derivatives, process for the preparation thereof and pharmaceutical composition containing the same
AP2002002595A0 (en) Heterocyclic amide derivatives.
AR019390A1 (es) Derivados de acidos sulfonilaminofosfinicos y sulfonilaminofosfonicos, procedimiento para su preparacion, compuestos intermediarios, medicamentos, procedimiento para su preparacion y empleo de dichos derivados para la preparacion de un medicamento.
AR036554A1 (es) Coniosulfuros y sus derivados, procedimiento para su preparacion y su utilizacion como medicamentos
ES455436A1 (es) Procedimiento de preparacion de acidos tienotienilcarbonife-nilalcanoicos.